TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25895202

Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin D (VD group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: 400 IU of vitamin D + 600 mg of calcium lactate (VD-Ca group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Multiple micronutrients with 400 IU of vitamin D + 600 mg of calcium lactate (MMN-VD-Ca group)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo (PL group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: All supplemented groups (VD, VD-Ca, MMN-VD-Ca)
Number of subjects: 200
Study: 22036512

Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (IUS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Copper-containing intrauterine contraceptive device (IUCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no device inserted)
Number of subjects: 0
Study: 20179914

Group type: EXPERIMENTAL
Intervention: Rifampicin 600 mg once daily for 5 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 17268208

Group type: EXPERIMENTAL
Intervention: Enhanced external counterpulsation (EECP) therapy
Number of subjects: 450
Study: 15297200

Group type: EXPERIMENTAL
Intervention: Topotecan (1.0 mg/m(2)/day on days 1 to 3) and Carboplatin (AUC 4 on day 1) followed by Paclitaxel (175 mg/m(2) via 3‐h IV infusion on day 1) and Carboplatin (AUC 5 on day 1)
Number of subjects: 45
Study: 12203747

Group type: EXPERIMENTAL
Intervention: Patient initiated follow up (n = 30, age range 53‐87 years)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard clinic follow up (n = 31, age range: 48‐83 years)
Number of subjects: 61
Study: 9830856

Group type: EXPERIMENTAL
Intervention: Age-based formula (AB) - (age in years +16) / 4
Number of subjects: 174

Group type: COMPARATOR
Intervention: Broselow pediatric resuscitation tape
Number of subjects: 174

Group type: COMPARATOR
Intervention: Age-based formula (AB) - (age in years +18) / 4
Number of subjects: 174
Study: 8089728

Group type: EXPERIMENTAL
Intervention: Vitamin A (retinyl palmitate) 210 mumol
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 2510268

Group type: EXPERIMENTAL
Intervention: Rioprostil, 300 micrograms b.d.
Number of subjects: 355

Group type: COMPARATOR
Intervention: Ranitidine, 150 mg b.d.
Number of subjects: 355
Study: 1102277

Group type: EXPERIMENTAL
Intervention: Thiothixene (Navane, Pfizer)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 31006818

Group type: EXPERIMENTAL
Intervention: Low-sodium cereal (LSC)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Regular-sodium cereal (RSC)
Number of subjects: 39
Study: 29179773

Group type: EXPERIMENTAL
Intervention: 15-s sustained inflation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Five repeated inflations of 2-3 s
Number of subjects: 40
Study: 24619991

Group type: EXPERIMENTAL
Intervention: Prenatal Qi exercise (90 minutes, twice a week for 12 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 70
Study: 23708168

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (hemoglobin level ≥10 g/dL)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (hemoglobin <8 g/dL or symptoms from anemia)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy
Number of subjects: 110

Group type: COMPARATOR
Intervention: Restrictive transfusion strategy
Number of subjects: 110
Study: 21387981

Group type: EXPERIMENTAL
Intervention: Oral irrigator with prototype jet tip
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Oral irrigator with standard jet tip
Number of subjects: 108

Group type: COMPARATOR
Intervention: Waxed dental floss
Number of subjects: 108
Study: 19217741

Group type: EXPERIMENTAL
Intervention: Asthma Numeracy Questionnaire (ANQ)
Number of subjects: 80
Study: 16827932

Group type: EXPERIMENTAL
Intervention: Metabolic syndrome
Number of subjects: 166
Study: 15570285

Group type: COMPARATOR
Intervention: Hydroxyurea (30 mg/kg/day)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Busulphan (0.1 mg/kg/day)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation (BMT)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Non-transplanted patients
Number of subjects: 179
Study: 11122135

Group type: EXPERIMENTAL
Intervention: 10 microg/kg G‐CSF once daily (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 5 microg/kg G‐CSF twice daily (n = 25)
Number of subjects: 50
Study: 9306119

Group type: EXPERIMENTAL
Intervention: Danazol
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: GnRH-analogue
Number of subjects: 40

Group type: COMPARATOR
Intervention: No pretreatment
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Gestagen
Number of subjects: 40
Study: 8290673

Group type: EXPERIMENTAL
Intervention: Thioridazine
Number of subjects: 35

Group type: COMPARATOR
Intervention: Molindone
Number of subjects: 35

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 35
Study: 2885188

Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 30
Study: 31188705

Group type: EXPERIMENTAL
Intervention: Active Lifestyle Program (ALP; n = 17)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard Care (n = 14)
Number of subjects: 31
Study: 29306465

Group type: EXPERIMENTAL
Intervention: fQRS at 60 minutes post-PCI
Number of subjects: 421

Group type: COMPARATOR
Intervention: No fQRS at 60 minutes post-PCI
Number of subjects: 421
Study: 27212247

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment (15‐20mg/kg/day) for 24 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment
Number of subjects: 34
Study: 24697979

Group type: EXPERIMENTAL
Intervention: Co-administration of naproxen 500 mg and apixaban 10 mg
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg
Number of subjects: 21

Group type: COMPARATOR
Intervention: Apixaban 10 mg
Number of subjects: 21
Study: 22331037

Group type: EXPERIMENTAL
Intervention: High soy diet (2 soy food servings per day)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Low soy diet (<3 servings per week)
Number of subjects: 82
Study: 20386992

Group type: EXPERIMENTAL
Intervention: Interim methadone (IM)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Waiting list (Control)
Number of subjects: 319
Study: 19045972

Group type: EXPERIMENTAL
Intervention: Biofeedback-based behavioral intervention (12 sessions over 3 months)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Wait-list control group (no treatment during intervention period)
Number of subjects: 130
Study: 15770007

Group type: EXPERIMENTAL
Intervention: Prostate cancer screening using PSA testing and DRE
Number of subjects: 38350

Group type: EXPERIMENTAL
Intervention: Diagnostic follow-up after positive screening tests
Number of subjects: 38350
Study: 12858327

Group type: EXPERIMENTAL
Intervention: Tianeptine
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10630793

Group type: EXPERIMENTAL
Intervention: AIK-C vaccine
Number of subjects: 135

Group type: COMPARATOR
Intervention: Schwarz vaccine
Number of subjects: 135

Group type: COMPARATOR
Intervention: Both vaccines
Number of subjects: 135
Study: 7717832

Group type: EXPERIMENTAL
Intervention: Adjusted dose heparin
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Functional electrical stimulation (FES)
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control
Number of subjects: 360
Study: 2044396

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (75 mg)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Dipyrone/spasmolytics
Number of subjects: 107

Group type: COMPARATOR
Intervention: Pethidine (75 mg)
Number of subjects: 107
Study: 7314025

Group type: EXPERIMENTAL
Intervention: Aminophylline and salbutamol together
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol and aminophylline
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol and aminophylline
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 29
Study: 30831045

Group type: EXPERIMENTAL
Intervention: Tetracaine eye drop (3 drops applied in four directions)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo or synthetic teardrop (3 drops applied in four directions)
Number of subjects: 70
Study: 28698876

Group type: EXPERIMENTAL
Intervention: Minimally Invasive Transforaminal Lumbar Interbody Fusion (MI TLIF)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard Transforaminal Lumbar Interbody Fusion (S TLIF)
Number of subjects: 80
Study: 26229203

Group type: EXPERIMENTAL
Intervention: Multimedia informed consent tool
Number of subjects: 311

Group type: COMPARATOR
Intervention: Standard procedure
Number of subjects: 311
Study: 23123509

Group type: EXPERIMENTAL
Intervention: nab-P/C (nab-paclitaxel 100 mg/m² weekly)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: sb-P/C (solvent-based paclitaxel 200 mg/m² day 1 every 3 weeks)
Number of subjects: 1052

Group type: EXPERIMENTAL
Intervention: nab-P/C
Number of subjects: 1052

Group type: COMPARATOR
Intervention: sb-P/C
Number of subjects: 1052
Study: 21330355

Group type: EXPERIMENTAL
Intervention: Focus on Kids (FOK) program
Number of subjects: 304
Study: 18367182

Group type: EXPERIMENTAL
Intervention: HP-hFSH
Number of subjects: 152

Group type: COMPARATOR
Intervention: rFSH
Number of subjects: 152
Study: 17768297

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 0
Study: 15030824

Group type: EXPERIMENTAL
Intervention: Healon5
Number of subjects: 157

Group type: COMPARATOR
Intervention: Healon
Number of subjects: 157
Study: 11302829

Group type: EXPERIMENTAL
Intervention: Itraconazole oral solution
Number of subjects: 0
Study: 9463082

Group type: EXPERIMENTAL
Intervention: Presence of serum IgG class anti-CMV antibodies in women following spontaneous abortions (n=11)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Presence of serum IgG class anti-HPV-B19 antibodies in women following spontaneous abortions (n=11)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Presence of IgM and IgG class antibodies against CMV and HPV-B19 in one patient
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group of women in the second trimester of a normal pregnancy (n=15)
Number of subjects: 26
Study: 8201852

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 16000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16000
Study: 3236319

Group type: EXPERIMENTAL
Intervention: Random zero sphygmomanometer
Number of subjects: 36

Group type: COMPARATOR
Intervention: Standard sphygmomanometer
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Arm supported position
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Arm dependent position
Number of subjects: 36
Study: 2195714

Group type: EXPERIMENTAL
Intervention: Nimodipine (30 mg q.i.d. for 28 days)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo (identical tablets for 28 days)
Number of subjects: 164
Study: 1096900

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetyl salicylic acid (ASA)
Number of subjects: 0
Study: 29777529

Group type: EXPERIMENTAL
Intervention: ADS-5102 (210, 274, or 338 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28203003

Group type: EXPERIMENTAL
Intervention: Group A (medication group, low dose aspirin)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Group B (withdrawal group)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Group C (control group)
Number of subjects: 69
Study: 26335129

Group type: EXPERIMENTAL
Intervention: Standard salpingectomy (Group A, n = 91)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Wide salpingectomy with mesosalpinx removal (Group B, n = 95)
Number of subjects: 186
Study: 23400807

Group type: EXPERIMENTAL
Intervention: Group Relevant
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group Irrelevant
Number of subjects: 0
Study: 21077915

Group type: EXPERIMENTAL
Intervention: Inappropriate ICD shocks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Appropriate ICD shocks
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Inappropriate ICD shocks (multivariable analysis)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Consideration of device deactivation
Number of subjects: 100
Study: 19465316

Group type: EXPERIMENTAL
Intervention: Detained youth
Number of subjects: 1653

Group type: COMPARATOR
Intervention: Males living in the community
Number of subjects: 1653

Group type: COMPARATOR
Intervention: Males incarcerated at follow-up
Number of subjects: 1653
Study: 16737871

Group type: COMPARATOR
Intervention: 50% RH
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 75% RH
Number of subjects: 22
Study: 15090564

Group type: EXPERIMENTAL
Intervention: Subcutaneous IFN beta‐1a, 22 micro g once weekly
Number of subjects: 371

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 371
Study: 11715631

Group type: EXPERIMENTAL
Intervention: Rob 10 (3 x 25 drops daily)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Rob 10
Number of subjects: 88
Study: 9207816

Group type: EXPERIMENTAL
Intervention: 9 prenatal visits (experimental group)
Number of subjects: 2328

Group type: COMPARATOR
Intervention: 14 prenatal visits (control group)
Number of subjects: 2328
Study: 8087826

Group type: EXPERIMENTAL
Intervention: Nitroglycerin infusion for 24 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine administration after nitroglycerin infusion
Number of subjects: 20
Study: 2969906

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional insulin treatment (CIT)
Number of subjects: 20
Study: 31863269

Group type: COMPARATOR
Intervention: Cancer-facts writing condition (CTL group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Emotional disclosure writing condition (EMO group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Self-regulation writing condition (SR group)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Neutral control condition with no writing tasks (CON group)
Number of subjects: 118
Study: 31039158

Group type: EXPERIMENTAL
Intervention: Conditional cash transfer (CCT) program
Number of subjects: 941

Group type: COMPARATOR
Intervention: No conditional cash transfer (CCT) program
Number of subjects: 941
Study: 28834360

Group type: EXPERIMENTAL
Intervention: RAS inhibitors
Number of subjects: 3848
Study: 25345681

Group type: EXPERIMENTAL
Intervention: Daily sessions of music-guided slow-breathing (<10 breaths/min) for 30 minutes
Number of subjects: 37

Group type: COMPARATOR
Intervention: Simple relaxation (control)
Number of subjects: 37
Study: 23480646

Group type: EXPERIMENTAL
Intervention: Ronnie Gardiner Rhythm and Music (RGRM™) Method
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 20798190

Group type: EXPERIMENTAL
Intervention: Ultrasound collapse pressure (UCP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: External jugular venous pressure (JVPEXT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internal jugular venous pressure (JVPINT)
Number of subjects: 0
Study: 18623908

Group type: EXPERIMENTAL
Intervention: Maraviroc (300 mg twice a day)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1076

Group type: EXPERIMENTAL
Intervention: Maraviroc
Number of subjects: 1076
Study: 16860173

Group type: EXPERIMENTAL
Intervention: Ciclesonide 80 microg QD
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg QD
Number of subjects: 554

Group type: COMPARATOR
Intervention: Budesonide 200 microg BID
Number of subjects: 554
Study: 12640507

Group type: EXPERIMENTAL
Intervention: Trandolapril (2 to 4 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Captopril (75 to 150 mg/day)
Number of subjects: 40
Study: 10584125

Group type: EXPERIMENTAL
Intervention: Curative radiotherapy for localized prostate cancer in elderly patients
Number of subjects: 59

Group type: COMPARATOR
Intervention: Curative radiotherapy for localized prostate cancer in younger patients
Number of subjects: 59
Study: 9112715

Group type: EXPERIMENTAL
Intervention: Symptom Satisfaction measure at 7 weeks
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Symptom Satisfaction measure at 1 year
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Predictors of poor outcomes at 7 weeks
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Predictors of poor outcomes at 1 year
Number of subjects: 219
Study: 1831633

Group type: EXPERIMENTAL
Intervention: Ondansetron (0.15 mg/kg, three intravenous doses 4-hourly)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoclopramide (2.0 mg/kg, six intravenous doses)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral Ondansetron (16 mg t.d.s.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ondansetron (subsequent courses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoclopramide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 0
Study: 6346845

Group type: EXPERIMENTAL
Intervention: Ethmozine (mean total daily dose of 830 mg +/- 318 mg, dosing every 8 hours)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ethmozine
Number of subjects: 39
Study: 29083986

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conscious Sedation (CS)
Number of subjects: 150
Study: 27396224

Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/kg (Group K, n = 91)
Number of subjects: 183

Group type: COMPARATOR
Intervention: Normal saline (Group P, n = 92)
Number of subjects: 183
Study: 24210534

Group type: EXPERIMENTAL
Intervention: Brief integrated intervention (BI)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: BI plus 9 further sessions with integrated-focus
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: BI plus 9 further sessions with alcohol-focus
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: BI plus 9 further sessions with depression-focus
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Longer interventions
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 284
Study: 22143524

Group type: EXPERIMENTAL
Intervention: Tigecycline (100 mg loading dose followed by 50 mg every 12 h for a minimum of 7 days)
Number of subjects: 61
Study: 20337827

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate shampoo 0.05%
Number of subjects: 0
Study: 18545212

Group type: EXPERIMENTAL
Intervention: 0.05% Mupirocin nasal lavage
Number of subjects: 16
Study: 15729063

Group type: EXPERIMENTAL
Intervention: Laparoscopic colonic resection with fast-track rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open colonic resection with fast-track rehabilitation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open colonic resection
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Laparoscopic colonic resection
Number of subjects: 60
Study: 12759479

Group type: EXPERIMENTAL
Intervention: Lung-volume-reduction surgery
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 1218
Study: 9571385

Group type: EXPERIMENTAL
Intervention: ASPD+
Number of subjects: 0

Group type: COMPARATOR
Intervention: AABS+
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASPD+ (180 days treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AABS+ (180 days treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ASPD+ (90 days treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AABS+ (90 days treatment)
Number of subjects: 0
Study: 7887657

Group type: EXPERIMENTAL
Intervention: Epiluminescence microscopy (ELM)
Number of subjects: 19
Study: 2220877

Group type: EXPERIMENTAL
Intervention: rHuEPO 100 mu/kg body weight three times/week subcutaneously
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: rHuEPO 150 mu/kg three times/week after 12 weeks of placebo
Number of subjects: 11
Study: 646969

Group type: EXPERIMENTAL
Intervention: Synthetic oestrogen (ethinyloestradiol)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Natural oestrogen (oestriol succinate)
Number of subjects: 9
Study: 31757635

Group type: EXPERIMENTAL
Intervention: Black walnuts (BW) meal
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: English walnuts (EW) meal
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (butter) meal
Number of subjects: 30
Study: 28746521

Group type: EXPERIMENTAL
Intervention: Playful workshops (8 sessions)
Number of subjects: 79
Study: 26014295

Group type: EXPERIMENTAL
Intervention: Androgen-deprivation therapy (ADT) with radiotherapy (RT)
Number of subjects: 1205

Group type: COMPARATOR
Intervention: Androgen-deprivation therapy (ADT) alone
Number of subjects: 1205
Study: 23217981

Group type: COMPARATOR
Intervention: Above-elbow cast (AEC) without percutaneous fixation
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Above-elbow cast (AEC) with percutaneous fixation using Kirschner wires
Number of subjects: 128
Study: 22008927

Group type: EXPERIMENTAL
Intervention: Cigarette smoking prevalence in males (35.9%)
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Cigarette smoking prevalence in age group 30-49 years
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Heavy smokers among smokers
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Regular flavor cigarette usage among smokers
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Attempts to quit smoking among smokers
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Methods of quitting smoking
Number of subjects: 7003

Group type: EXPERIMENTAL
Intervention: Daily media habits of smokers
Number of subjects: 7003
Study: 19629378

Group type: EXPERIMENTAL
Intervention: LigaSure hemorrhoidectomy
Number of subjects: 80

Group type: COMPARATOR
Intervention: Closed Ferguson hemorrhoidectomy
Number of subjects: 80